April 21, 2026
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in developme...
April 21, 2026
The exosome diagnostic and therapeutic market focuses on innovative research for diagnosing health disorders and monitoring treatments. Exosomes, found in body fluids, are used in cancer therapy, immune modulation, and drug delivery. Companies like C...
April 21, 2026
The therapeutic neurotoxin market was valued at USD 6.39 billion in 2025 and is projected to reach USD 6.94 billion in 2026, expanding to approximately USD 14.5 billion by 2035 at a CAGR of 8.54% 2026 to 2035. The report covers detailed segment analy...
April 13, 2026
Pet Therapeutic Diet Market (By Pet Type: Dogs, Cats, Other; By Indication: Digestive Health, Renal Health,Weight Management, Diabetes Care, Cardiac Health,Allergy & Skin Care, Joint & Mobility Support, Liver Health; By Product Type...
April 21, 2026
According to market projections, the global plasma fractionation market, valued at USD 37.87 billion in 2025, is anticipated to reach USD 78.34 billion by 2035, growing at a CAGR of 7.54% over the next decade. The rising therapeutic demand for plasma...
April 21, 2026
According to market projections, the therapeutic drug monitoring (TDM) sector is expected to grow from USD 1.92 billion in 2024 to USD 2.8 billion by 2034, reflecting a CAGR of 3.84%. Globally, the rising prevalence of chronic diseases, along with th...
April 21, 2026
Projections indicate that, the global stem cell banking market will increase from USD 9.12 billion in 2025 to USD 40.72 billion by 2035, experiencing a CAGR of 16.14% over the next 10 years. The market is expanding due to the rising prevalence of chr...
April 21, 2026
According to market projections, the global albumin pharma market, valued at USD 6.77 billion in 2024, is anticipated to reach USD 11.72 billion by 2034, growing at a CAGR of 5.65% over the next decade. The rising prevalence of chronic diseases such ...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
April 21, 2026
According to market projections, the global liver disease therapeutics market, valued at USD 26.54 billion in 2025, is anticipated to reach USD 45.25 billion by 2035, growing at a CAGR of 5.48% over the next decade. The liver disease therapeutics mar...
February 16, 2026
According to market projections, the digital therapeutics sector is expected to grow from USD 9.84 billion in 2025 to USD 114.37 billion by 2035, reflecting a CAGR of 27.8%. The market is growing due to the rising need for effective, remote healthcar...
April 21, 2026
The molecule therapeutics market is growing due to the field of molecular therapeutics is significant in medicine and human biology, as it provides novel information on the discovery, diagnosis, and treatment of present and emerging diseases....
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited ...
February 26, 2026
Market insights predict, the RNA therapeutics and vaccines industry is expected to grow from USD 0.39 billion in 2025 to USD 205.34 billion by 2035, driven by a CAGR of 87%. The RNA therapeutics and vaccines market is growing as it is an innovative a...
April 21, 2026
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest ...
February 17, 2026
The global cystic fibrosis therapeutics market expected to reach USD 44.72 billion by 2035, growing at a CAGR of 14.24% over the forecast period. In 2024, North America dominated the market, while Asia-Pacific is set for the fastest growth. CFTR modu...
April 21, 2026
According to market projections, the protein therapeutics market sector is expected to grow from USD 375.3 billion in 2024 to USD 740.07 billion by 2034, reflecting a CAGR of 7.08%. The protein therapeutics market is expanding due to increasing disea...
April 21, 2026
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and researc...
April 21, 2026
Forecasts suggest that the synovial sarcoma treatment market will expand from USD 852.36 million in 2024 to USD 1214 million by 2034, with a CAGR of 3.6% during this period. In 2023, surgery remained the leading treatment, holding a dominant 56% mark...
April 21, 2026
Market insights predict the global RNAi therapeutics industry will increase from USD 1.28 billion in 2024 to USD 5.11 billion by 2034, achieving a CAGR of 14.9%. In 2023, siRNA therapy dominated with a 64% market share, leading the RNA-based treatmen...
April 21, 2026
Projections indicate that, the global allergy diagnostics and therapeutics market will increase from USD 36.55 billion in 2025 to USD 84.59 billion by 2035, experiencing a CAGR of 8.76% over the next 10 years. The market is growing due to the rising ...
April 21, 2026
The single-cell biotherapeutics market is growing because single-cell technologies have accomplished significant achievements in diagnosing and treating different tumors, such as breast tumors, lung tumors, and gliomas....
April 21, 2026
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COP...
April 21, 2026
G-Protein Coupled Receptors Market (By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands; By Assay Type: cAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding & GTPγS Fun...
February 03, 2026
The evolving usage of plasmids and vectors in various applications is driving the market’s growth. Based on market forecasts, the global viral vector and plasmid DNA manufacturing market, projected at USD 8.77 billion in 2025, is expected to re...
April 21, 2026
According to market projections, the digital psychotherapeutics sector is expected to grow from USD 1.69 billion in 2024 to USD 20.66 billion by 2034, reflecting a CAGR of 28.24%. In 2024, North America led the digital psychotherapeutics market. Asia...
April 21, 2026
Based on market forecasts, the stroke diagnostics and therapeutics sector will expand from USD 38.03 billion in 2024 to USD 76.23 billion by 2034, experiencing a CAGR of 7.2%. Stroke diagnostics and therapeutics focus on quickly identifying and treat...
April 13, 2026
Peptide Therapeutics Market(By Type: Branded Peptide Drugs, Generic Peptide Drugs, By Route of Administration: Parenteral, Oral, Transdermal & Others, By Application/Therapeutic: Area Oncology, Metabolic Disorders, Infectious Diseases, Cardiov...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alc...
April 21, 2026
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
April 21, 2026
Market insights predict the global antisense and RNAi therapeutics industry will increase from USD 6.19 billion in 2024 to USD 35.63 billion by 2034, achieving a CAGR of 19.12%. Funding for research and development of rare diseases is promoting the m...
April 17, 2026
Biosimilar Contract Manufacturing Market (By Source: Mammalian, Non-mammalian; By Services: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins; By Therapeutic Area: Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic ...
April 23, 2026
Digital Therapeutics for Mental Health Market (By Product Type: Software-Based Digital Therapeutics, Hardware-Based Digital Therapeutics; By Application: Depression, Anxiety, Substance Use Disorders, Cognitive Disorders, Post-Traumatic Stress Disorde...
April 21, 2026
The gene-editing therapeutics market is expanding due to growing advancements in gene editing technologies as well as their increasing applications. North America led the market due to the presence of the largest cluster of sponsors. ...
April 21, 2026
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive th...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
April 23, 2026
Hereditary Angioedema Therapeutics Market (By Drug Class: C1 Esterase Inhibitors, Kallikrein Inhibitors, Bradykinin B2 Receptor Antagonists, Others; By Route of Administration: Intravenous, Subcutaneous, Oral; By Treatment Type: On-demand Treatment, ...
April 16, 2026
Aptamers Market (By Type: Nucleic Acid Aptamer, Peptide Aptamer; By Application: Diagnostics, Therapeutics, Research & Development, Others; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Si...
April 21, 2026
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy...